HIV-1 uncoating: connection to nuclear entry and regulation by host proteins.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Virology

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.virol.2014.02.004PMID 24559861PMCID PMC3988234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vivo Functions of CPSF6 for HIV-1 as Revealed by HIV-1 Capsid Evolution in HLA-B27-Positive Subjects

  2014cited by this paper
• The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells.

  2013cited by this paper
• The interferon-inducible MxB protein inhibits HIV-1 infection.

  2013cited by this paper
• Nuclear import of APOBEC3F-labeled HIV-1 preintegration complexes

  2013cited by this paper
• TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm

  2013cited by this paper
• Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay

  2013cited by this paper
• Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics

  2013cited by this paper
• Extreme genetic fragility of the HIV-1 capsid

  2013cited by this paper
• Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection

  2013cited by this paper
• MX2 is an interferon-induced inhibitor of HIV-1 infection

  2013cited by this paper
• Extreme Genetic Fragility of the HIV-1 Capsid

  2013cited by this paper
• HIV-1 evades innate immune recognition through specific co-factor recruitment

  2013cited by this paper
• Fates of Retroviral Core Components during Unrestricted and TRIM5-Restricted Infection

  2013cited by this paper
• The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6

  2013cited by this paper
• Nucleoporin NUP153 Phenylalanine-Glycine Motifs Engage a Common Binding Pocket within the HIV-1 Capsid Protein to Mediate Lentiviral Infectivity

  2013cited by this paper
• The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid

  2013cited by this paper
• Discovery of Novel Small-Molecule HIV-1 Replication Inhibitors That Stabilize Capsid Complexes

  2013cited by this paper
• Cyclophilin A-Dependent Restriction to Capsid N121K Mutant Human Immunodeficiency Virus Type 1 in a Broad Range of Cell Lines

  2013cited by this paper
• Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects

  2012cited by this paper
• Human Immunodeficiency Virus Type 1 Capsid Mutation N74D Alters Cyclophilin A Dependence and Impairs Macrophage Infection

  2012cited by this paper
• CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication

  2012cited by this paper
• Distinct Effects of Two HIV-1 Capsid Assembly Inhibitor Families That Bind the Same Site within the N-Terminal Domain of the Viral CA Protein

  2012cited by this paper
• Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors

  2012cited by this paper
• Inhibiting Early-Stage Events in HIV-1 Replication by Small-Molecule Targeting of the HIV-1 Capsid

  2012cited by this paper
• Inhibition of Reverse Transcriptase Activity Increases Stability of the HIV-1 Core

  2012cited by this paper
• The Host Proteins Transportin SR2/TNPO3 and Cyclophilin A Exert Opposing Effects on HIV-1 Uncoating

  2012cited by this paper
• Second-Site Compensatory Mutations of HIV-1 Capsid Mutations

  2011cited by this paper
• In vitro uncoating of HIV-1 cores.

  2011cited by this paper
• Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus

  2011cited by this paper
• HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, Integration Targeting and Replication Efficiency

  2011cited by this paper
• RING Domain Mutations Uncouple TRIM5α Restriction of HIV-1 from Inhibition of Reverse Transcription and Acceleration of Uncoating

  2011cited by this paper
• Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription

  2011cited by this paper
• Direct visualization of HIV-1 with correlative live-cell microscopy and cryo-electron tomography.

  2011cited by this paper
• Rhesus TRIM5α Disrupts the HIV-1 Capsid at the InterHexamer Interfaces

  2011cited by this paper
• Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Infection by Virus Capsid Destabilization

  2010cited by this paper
• Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1*

  2010cited by this paper
• Flexible use of nuclear import pathways by HIV-1.

  2010cited by this paper
• Hexagonal assembly of a restricting TRIM5α protein

  2010cited by this paper
• A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells

  2010cited by this paper
• A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells.

  2010cited by this paper
• HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention

  2010cited by this paper
• TRIM5α Disrupts the Structure of Assembled HIV-1 Capsid Complexes In Vitro

  2010cited by this paper
• X-ray structures of the hexameric building block of the HIV capsid.

  2009cited by this paper
• Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function.

  2009cited by this paper
• Cellular Restriction Targeting Viral Capsids Perturbs Human Immunodeficiency Virus Type 1 Infection of Nondividing Cells

  2009cited by this paper
• The Requirement for Cellular Transportin 3 (TNPO3 or TRN-SR2) during Infection Maps to Human Immunodeficiency Virus Type 1 Capsid and Not Integrase

  2009cited by this paper
• Maturation of the HIV reverse transcription complex: putting the jigsaw together

  2009cited by this paper
• Target Cell Type-Dependent Modulation of Human Immunodeficiency Virus Type 1 Capsid Disassembly by Cyclophilin A

  2009cited by this paper
• Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5α

  2008cited by this paper
• Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen

  2008cited by this paper
• A cell-penetrating helical peptide as a potential HIV-1 inhibitor.

  2008cited by this paper
• HIV-1 Pre-Integration Complexes Selectively Target Decondensed Chromatin in the Nuclear Periphery

  2008cited by this paper
• Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.

  2008cited by this paper
• Genome-scale RNAi screen for host factors required for HIV replication.

  2008cited by this paper
• Biochemical Characterization of a Recombinant TRIM5α Protein That Restricts Human Immunodeficiency Virus Type 1 Replication

  2008cited by this paper
• Cyclophilin A-Dependent Restriction of Human Immunodeficiency Virus Type 1 Capsid Mutants for Infection of Nondividing Cells

  2008cited by this paper
• Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent

  2008cited by this paper
• Article Transportin-SR2 Imports HIV into the Nucleus

  2008cited by this paper
• VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability

  2008cited by this paper
• The effect of capsid mutations on HIV-1 uncoating.

  2007cited by this paper
• A Mutation in Alpha Helix 3 of CA Renders Human Immunodeficiency Virus Type 1 Cyclosporin A Resistant and Dependent: Rescue by a Second-Site Substitution in a Distal Region of CA

  2007cited by this paper
• Analysis of Human Cell Heterokaryons Demonstrates that Target Cell Restriction of Cyclosporine-Resistant Human Immunodeficiency Virus Type 1 Mutants Is Genetically Dominant

  2007cited by this paper
• Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.

  2007cited by this paper
• Evidence for Direct Involvement of the Capsid Protein in HIV Infection of Nondividing Cells

  2007cited by this paper
• HIV‐1 DNA Flap formation promotes uncoating of the pre‐integration complex at the nuclear pore

  2007cited by this paper
• Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication

  2007cited by this paper
• Structure of full-length HIV-1 CA: a model for the mature capsid lattice.

  2007cited by this paper
• Cell Factors Stimulate Human Immunodeficiency Virus Type 1 Reverse Transcription In Vitro

  2007cited by this paper
• A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein.

  2007cited by this paper
• Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.

  2006cited by this paper
• Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes

  2006cited by this paper
• Evidence for a Functional Link between Uncoating of the Human Immunodeficiency Virus Type 1 Core and Nuclear Import of the Viral Preintegration Complex

  2006cited by this paper
• Trim-Cyclophilin A Fusion Proteins Can Restrict Human Immunodeficiency Virus Type 1 Infection at Two Distinct Phases in the Viral Life Cycle

  2006cited by this paper
• Proteasome Inhibition Reveals that a Functional Preintegration Complex Intermediate Can Be Generated during Restriction by Diverse TRIM5 Proteins

  2006cited by this paper
• Trim5α Accelerates Degradation of Cytosolic Capsid Associated with Productive HIV-1 Entry*

  2006cited by this paper
• Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection.

  2006cited by this paper
• Cyclophilin Interactions with Incoming Human Immunodeficiency Virus Type 1 Capsids with Opposing Effects on Infectivity in Human Cells

  2005cited by this paper
• The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor

  2005cited by this paper
• Virus Particle Core Defects Caused by Mutations in the Human Immunodeficiency Virus Capsid N-Terminal Domain

  2005cited by this paper
• AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis

  2005cited by this paper
• Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1

  2004cited by this paper
• Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

  2004cited by this paper
• Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells

  2004cited by this paper
• The stoichiometry of Gag protein in HIV-1

  2004cited by this paper
• The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys

  2004cited by this paper
• Trim5α protein restricts both HIV-1 and murine leukemia virus

  2004cited by this paper
• Target Cell Cyclophilin A Modulates Human Immunodeficiency Virus Type 1 Infectivity

  2004cited by this paper
• Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein

  2003cited by this paper
• PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

  2003cited by this paper
• Disassembly of Human Immunodeficiency Virus Type 1 Cores In Vitro Reveals Association of Nef with the Subviral Ribonucleoprotein Complex

  2003cited by this paper
• Antiviral inhibition of the HIV-1 capsid protein.

  2003cited by this paper
• Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A

  2002cited by this paper
• Visualization of the intracellular behavior of HIV in living cells

  2002cited by this paper
• Formation of a Human Immunodeficiency Virus Type 1 Core of Optimal Stability Is Crucial for Viral Replication

  2002cited by this paper
• Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism

  2002cited by this paper
• Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants That Exhibit Aberrant Core Morphology and Are Blocked in Initiation of Reverse Transcription in Infected Cells

  2001cited by this paper
• Characterization of Intracellular Reverse Transcription Complexes of Human Immunodeficiency Virus Type 1

  2001cited by this paper
• Cyclophilin A-Independent Replication of a Human Immunodeficiency Virus Type 1 Isolate Carrying a Small Portion of the Simian Immunodeficiency Virus SIVMACgag Capsid Region

  2001cited by this paper
• Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses

  2001cited by this paper
• Image reconstructions of helical assemblies of the HIV-1 CA protein

  2000cited by this paper

• Stoichiometric binding of Cyclophilin-A to the HIV-1 capsid modulates its mechanoelastic properties

  2026cites this paper
• Analysis of Hepatic Lentiviral Vector Transduction: Implications for Preclinical Studies and Clinical Gene Therapy Protocols

  2025cites this paper
• Spatiotemporal binding of cyclophilin A and CPSF6 to capsid regulates HIV-1 nuclear entry and integration

  2025cites this paper
• Column-Free Purification of Functional HIV-1 Capsid Protein and Its Application in Assembly and Inhibitor Assays.

  2025cites this paper
• The Confluence of HIV-1 and HIV-2: Implications for Disease Progression and Insights for Therapy

  2025cites this paper
• Profiling HIV1-host protein–protein interaction networks in patient-derived exosome proteins: impact on pathophysiology and innate immune pathways

  2025cites this paper
• Organoselenium Compounds in Medicinal Chemistry

  2024cites this paper
• Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocols

  2024cites this paper
• A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection

  2024cites this paper
• Current status of the small molecule anti-HIV drugs in the pipeline or recently approved.

  2024cites this paper
• A Branched SELEX Approach Identifies RNA Aptamers That Bind Distinct HIV-1 Capsid Structural Components

  2024cites this paper
• Cyclophilin inhibition as a strategy for the treatment of human disease

  2024cites this paper
• From Entry to the Nucleus: How Retroviruses Commute.

  2024cites this paper
• HIV-1 uncoating requires long double-stranded reverse transcription products

  2024cites this paper
• Spatiotemporal binding of cyclophilin A and CPSF6 to capsid regulates HIV-1 nuclear entry and integration

  2024cites this paper
• HIV-1 capsid stability and reverse transcription are finely balanced to minimize sensing of reverse transcription products via the cGAS-STING pathway

  2024cites this paper
• Capsid–host interactions for HIV-1 ingress

  2023cites this paper
• HIV-1 capsid and viral DNA integration

  2023cites this paper
• Differentiation SELEX approach identifies RNA aptamers with different specificities for HIV-1 capsid assembly forms

  2023cites this paper
• HIV-1-induced nuclear invaginations mediated by VAP-A, ORP3, and Rab7 complex explain infection of activated T cells

  2023cites this paper
• Maternal embryonic leucine zipper kinase (MELK) optimally regulates the HIV-1 uncoating process.

  2022cites this paper
• HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection

  2022cites this paper
• Anti-HIV Activity of Snake Venom Phospholipase A2s: Updates for New Enzymes and Different Virus Strains

  2022cites this paper
• The Effect of Treatment-Associated Mutations on HIV Replication and Transmission Cycles

  2022cites this paper
• Dual targeting inhibitors for HIV-1 capsid and cyclophilin A: molecular docking, molecular dynamics, and quantum mechanics

  2022influential citation
• HIV-1 capsid exploitation of the host microtubule cytoskeleton during early infection

  2021cites this paper
• Optimized Microbial Recombinant Production of HIV-1 Anti-Envelope Antibody Fragments with Applications to Single Particle Tracking of Virus Assembly

  2021cites this paper
• The HIV-1 Capsid: From Structural Component to Key Factor for Host Nuclear Invasion

  2021cites this paper
• HIV-1 capsid variability: viral exploitation and evasion of capsid-binding molecules

  2021cites this paper
• Intercellular Communication in the Nervous System Goes Viral.

  2021cites this paper
• HIV-1 Uncoating Occurs via a Series of Rapid Biomechanical Changes in the Core Related to Individual Stages of Reverse Transcription

  2021cites this paper
• HIV-1 mutants that escape the cytotoxic T-lymphocytes are defective in viral DNA integration

  2021cites this paper
• Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases

  2021cites this paper
• Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs—First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor

  2021cites this paper
• Saccharomyces cerevisiae RNA lariat debranching enzyme, Dbr1p, is required for completion of reverse transcription by the retrovirus-like element Ty1 and cleaves branched Ty1 RNAs

  2021cites this paper
• Structure, Function, and Interactions of the HIV-1 Capsid Protein

  2021cites this paper
• A lysine ring in HIV capsid pores coordinates IP6 to drive mature capsid assembly

  2021cites this paper
• HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV

  2021cites this paper
• The Role of Capsid in the Early Steps of HIV-1 Infection: New Insights into the Core of the Matter

  2021cites this paper
• Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules

  2020cites this paper
• Design, Synthesis, and Mechanism Study of Benzenesulfonamide-containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.

  2020cites this paper
• Capsid-Labelled HIV To Investigate the Role of Capsid during Nuclear Import and Integration

  2020cites this paper
• HIV-1 uncoats in the nucleus near sites of integration

  2020cites this paper
• Capsid Lattice Destabilization Leads to Premature Loss of the Viral Genome and Integrase Enzyme during HIV-1 Infection

  2020cites this paper
• TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner

  2020cites this paper
• Characterization Of The Anti-Viral Activity Of Schlafen13

  2020cites this paper
• Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes

  2020cites this paper
• From Entry to Egress: Strategic Exploitation of the Cellular Processes by HIV-1

  2020cites this paper
• A computational investigation of particle acoustic agglomeration in a resonance tube

  2020cites this paper
• Reconstitution and visualization of HIV-1 capsid-dependent replication and integration in vitro

  2020cites this paper
• Retrovirus Restriction Factor TRIM5α: The Mechanism of Action and Prospects for Use in Gene Therapy of HIV Infection

  2020cites this paper
• Atomic-resolution structure of HIV-1 capsid tubes by magic-angle spinning NMR

  2020cites this paper
• HIV‐1 capsids mimic a microtubule regulator to coordinate early stages of infection

  2020cites this paper
• Novel HIV-1 capsid-targeting small molecules of the PF74 binding site.

  2020cites this paper
• Cone-shaped HIV-1 capsids are transported through intact nuclear pores

  2020cites this paper
• TRIM34 restricts HIV-1 and SIV capsids in a TRIM5alpha-dependent manner

  2020cites this paper
• Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner

  2020influential citation
• Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner

  2020cites this paper
• Chemical profiling of HIV-1 capsid-targeting antiviral PF74.

  2020cites this paper
• Permeability of the HIV-1 capsid to metabolites modulates viral DNA synthesis

  2020cites this paper
• Microtubule Retrograde Motors and Their Role in Retroviral Transport

  2020cites this paper
• A simple, high-throughput stabilization assay to test HIV-1 uncoating inhibitors

  2019cites this paper
• Design of reverse transcriptase–specific nucleosides to visualize early steps of HIV-1 replication by click labeling

  2019cites this paper
• HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex

  2019cites this paper
• CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes

  2019cites this paper
• Novel Intersubunit Interaction Critical for HIV-1 Core Assembly Defines a Potentially Targetable Inhibitor Binding Pocket

  2019cites this paper
• GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds

  2019cites this paper
• Off-Pathway Assembly: A Broad-Spectrum Mechanism of Action for Drugs That Undermine Controlled HIV-1 Viral Capsid Formation

  2019cites this paper
• Restriction of HIV-1 and other retroviruses by TRIM5

  2019cites this paper
• Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes

  2019cites this paper
• Discovery and Development of Anti-HIV Therapeutic Agents: Progress Towards Improved HIV Medication

  2019cites this paper
• Immune Control of HIV.

  2019cites this paper
• Capsid-CPSF6 interaction: Master regulator of nuclear HIV-1 positioning and integration.

  2019cites this paper
• Org Immune Control of HIV

  2019cites this paper
• Attenuation of macrophage IL-10 responses by HIV-1

  2019cites this paper
• Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating

  2019cites this paper
• HIV Capsid Inhibitors Beyond PF74

  2019cites this paper
• Supercharged Assembly: A Broad-Spectrum Mechanism of Action for Drugs that Undermine Controlled HIV-1 Viral Capsid Formation

  2019cites this paper
• Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle

  2019cites this paper
• TRIM34 acts with TRIM5 to restrict HIV and SIV capsids

  2019cites this paper
• Analysis of CA Content and CPSF6 Dependence of Early HIV-1 Replication Complexes in SupT1-R5 Cells

  2019cites this paper
• A Novel Phenotype Links HIV-1 Capsid Stability to cGAS-Mediated DNA Sensing

  2019cites this paper
• PF74 Reinforces the HIV-1 Capsid To Impair Reverse Transcription-Induced Uncoating

  2018cites this paper
• Maedi-visna virus as a model for HIV

  2018cites this paper
• Host Restriction Factors and Human Immunodeficiency Virus (HIV-1): A Dynamic Interplay Involving All Phases of the Viral Life Cycle.

  2018cites this paper
• Design and Synthesis of potent benzimidazolone HIV Non-nucleoside reverse transcriptase inhibitors

  2018cites this paper
• Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library.

  2018cites this paper
• Y-box-binding protein 1 supports the early and late steps of HIV replication

  2018cites this paper
• Impact des inhibiteurs de l'intégrase sur la constitution et la compartimentalisation du réservoir viral

  2018cites this paper
• Live-Cell Imaging of Early Steps of Single HIV-1 Infection

  2018cites this paper
• Single HIV-1 Imaging Reveals Progression of Infection through CA-Dependent Steps of Docking at the Nuclear Pore, Uncoating, and Nuclear Transport.

  2018cites this paper
• Truncated CPSF6 Forms Higher-Order Complexes That Bind and Disrupt HIV-1 Capsid

  2018cites this paper
• Toward the “unravelling” of HIV: Host cell factors involved in HIV-1 core uncoating

  2018cites this paper
• PF74 Inhibits HIV-1 Integration by Altering the Composition of the Preintegration Complex

  2018cites this paper
• Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.

  2018cites this paper
• Vesiculovirus G protein-based stable cell lines for continuous lentiviral vector production

  2018cites this paper
• Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis

  2018cites this paper
• Are microRNAs Important Players in HIV-1 Infection? An Update

  2018cites this paper
• Nuclear Pore Complexes, Genome Organization and HIV-1 Infection

  2018cites this paper
• The Retrovirus Capsid Core.

  2018cites this paper